Longitudinal Patterns of Chemotherapy Use in Metastatic Colorectal Cancer
Authors:
- 1 September 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 5 (5) , 228-233
Abstract
Multiple agents and combination therapies available to patients with advanced colorectal cancer have significantly improved survival and provided an opportunity for individualization of care, allowing clinicians and patients to prioritize risks and benefits of comparable regimens.Keywords
This publication has 17 references indexed in Scilit:
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008
- Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803Journal of Clinical Oncology, 2007
- The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal CancerThe Oncologist, 2007
- Analysis of Treatment Practices for Elderly Cancer Patients in Ontario, CanadaJournal of Clinical Oncology, 2005
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Who Gets Adjuvant Treatment for Stage II and III Rectal Cancer? Insight From Surveillance, Epidemiology, and End Results–MedicareJournal of Clinical Oncology, 2001
- Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon CancerJNCI: Journal of the National Cancer Institute, 2001
- Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)European Journal of Cancer, 1999
- Adjuvant or Palliative Chemotherapy for Colorectal Cancer in Patients 70 Years or OlderJournal of Clinical Oncology, 1999